Citius Oncology Plunges 18.6% Amid Volatility

Citius Oncology's stock price dropped 18.6% in pre-market trading on April 1, 2025.

Citius Oncology's stock price has experienced significant volatility in recent sessions. On March 31st, the stock surged 84.96% in pre-market trading, reaching $1.23. This dramatic increase followed a 64% jump in the previous session, adding to a 1.5% gain from the session before. However, the stock has also seen declines, with a 12.31% drop to $0.82 in after-hours trading on April 1st, following a 29.85% rise to $0.87 during Monday's after-hours session. The market value of their outstanding shares is at $60.8 million.

These fluctuations reflect the high level of investor interest and speculation surrounding Citius Oncology, as well as the potential for significant price movements in the near term. Investors should closely monitor the company's developments and market conditions to make informed decisions about their investments.